Clinical Trial Update: Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia [Phase 3]

View source ↗

Summary

Phase 3 trial of levonorgestrel-releasing intrauterine system for endometrial hyperplasia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Hyperplasia

Drugs mentioned

• Levonorgestrel-Releasing Intrauterine System (levonorgestrel-releasing intrauterine system)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Endometrial Hyperplasia | Phase 3 | Status: WITHDRAWN